반응식
[N:1]1([CH2:6][C:7]([OH:9])=O)[CH2:5][CH2:4][CH2:3][CH2:2]1.C(N1C=CN=C1)(N1C=CN=C1)=O.[Cl:22][C:23]1[C:28]2[C:29](=[O:43])[N:30]3[CH2:42][CH2:41][C@H:31]3[C:32]3[N:33]([CH:34]=[N:35][C:36]=3[C:37](=[N:39]O)[NH2:38])[C:27]=2[CH:26]=[CH:25][CH:24]=1.C1(C)C=CC(S(O)(=O)=O)=CC=1>CN(C)C=O>[Cl:22][C:23]1[C:28]2[C:29](=[O:43])[N:30]3[CH2:42][CH2:41][C@H:31]3[C:32]3[N:33]([CH:34]=[N:35][C:36]=3[C:37]3[N:39]=[C:7]([CH2:6][N:1]4[CH2:2][CH2:3][CH2:4][CH2:5]4)[O:9][N:38]=3)[C:27]=2[CH:26]=[CH:25][CH:24]=1참가 물질
실험 절차
2.55 g (13.5 mmol) of 1-pyrrolidine-acetic acid were dissolved in 20 ml of N,N-dimethylformamide and treated portionwise with 2.6 g (15.9 mmol) of 1,1'-carbonyldiimidazole. After stirring for 45 minutes 3.9 g (12.3 mmol) of (S)-8-chloro-12,12a-dihydro-9-oxo-9H,11H- azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepine-1-carboxamidoxime were added and the mixture was stirred at 90° overnight. 0.2 g of p-toluenesulphonic acid was added and the mixture was stirred at 90° for a further 4 hours. The reaction mixture was concentrated. By chromatography of the residue on silica gel while eluting with methylene chloride/methanol 19/1 and recrystallization from ethyl acetate and hexane there were obtained 1.6 g (32%) of (S)-8-chloro-12,12a-dihydro-1-[5-(pyrrolidin-1-ylmethyl)-1,2,4-oxadiazol-3-yl]-9H,11H-azeto[2,1-c]imidazo[1,5-a][1,4]benzodiazepin-9-one of m.p. 117°-120°, which was converted into the hydrochloride.
후처리
- additionwere added
- stirringthe mixture was stirred at 90° for a further 4 hours
- concentrationThe reaction mixture was concentrated
- washBy chromatography of the residue on silica gel while eluting with methylene chloride/methanol 19/1 and recrystallization from ethyl acetate
출처 및 근거
- ORD 기록
- ord-c6799e52443444a1a28cf3624a5122d6
- 출처 데이터셋
- uspto-grants-1997_09
- 특허 번호
- US05665718
연결된 노트
불러오는 중…